Alzheimer disease

 
Exercise of Any Level Linked to Reduced All-Cause Mortality in Individuals with Dementia
November 19, 2024

Physical activity of any level before and after a diagnosis of dementia was associated with at least a 20% lower risk for all-cause mortality across dementia subtypes.

Agitation in Alzheimer Disease and Antipsychotics Used Off-Label are Not Meant for Each Other
November 18, 2024

Antipsychotic medications are still used to treat potentially harmful acute agitation, George Grossberg, MD, explains, even though the adverse effects are well known.

European Medicines Agency Reverses Opinion on Lecanemab for Alzheimer Disease But Limits Eligible Population
November 15, 2024

The EMA recommendation excludes from treatment adults who are homozygous for the ApoE ε4 gene, a decision that the US Alzheimer's Association does not support, said the president/CEO.

Nonpharmacologic Options for Agitation in Alzheimer Disease Should Always Come First: Expert Insights
November 15, 2024

Nondrug approaches to calming an adult with Alzheimer disease who is agitated should be prioritized over pharmacotherapy, geriatric psychiatrist George Grossberg, MD, counsels.

Environment is a Primary Nonpharmacologic Intervention to Reduce Agitation in Alzheimer Disease, Geriatric Psychiatrist Explains
November 14, 2024

When a patient with Alzheimer dementia becomes agitated, check the physical environment for a trigger before pulling the trigger on a medication, dementia expert George Grossberg, MD, recommends.

Alzheimer Disease Insights: It's Not All About Cognition, Counsels George Grossberg, MD
November 13, 2024

The geriatric psychiatrist refers in this interview to agitation in Alzheimer disease, a significant neuropsychiatric symptom that should not be dismissed.

Adjusted Donanemab Dosing Lowers ARIA-E Risk in Early Alzheimer Disease: Daily Dose
November 13, 2024

Your daily dose of the clinical news you may have missed.

Agitation-Type Behavior Occurs Across the Spectrum of Alzheimer Disease Severity, Advises Expert
November 06, 2024

Agitation in Alzheimer disease is not limited to the later stages, geriatric psychiatrist George Grossberg, MD, explains; look for it across the spectrum.

Agitation in Alzheimer Disease: A Behavioral Snapshot with Geriatric Psychiatrist George Grossberg, MD
November 05, 2024

Agitation is the most common disabling neuropsychiatric symptom experienced by individuals with Alzheimer dementia; Grossberg explains how common in this short interview.

Semaglutide May Reduce Alzheimer’s Risk in Adults with T2D: Daily Dose
November 05, 2024

Your daily dose of the clinical news you may have missed.